Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 27 for:    Behaviors and Mental Disorders[CONDITION-BROWSE-BRANCH] | Recruiting, Not yet recruiting, Available Studies | ( Map: Utah, United States ) | NIH, U.S. Fed
Previous Study | Return to List | Next Study

A Brief Mind-Body Bridging Intervention for Suicidal Ideation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03677882
Recruitment Status : Recruiting
First Posted : September 19, 2018
Last Update Posted : April 26, 2019
Sponsor:
Collaborator:
Mind Body Bridging Charity
Information provided by (Responsible Party):
VA Salt Lake City Health Care System

Brief Summary:
The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (TAU).

Condition or disease Intervention/treatment Phase
Suicidal Ideation Mind Body Bridging Behavioral: Mind Body Bridging Group Session Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Pilot Study of a Brief Mind-Body Bridging Intervention for Suicidal Ideation
Actual Study Start Date : December 18, 2018
Estimated Primary Completion Date : October 31, 2020
Estimated Study Completion Date : October 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide

Arm Intervention/treatment
No Intervention: Treatment as Usual (TAU)
Participants assigned to Treatment As Usual (TAU) will receive the normal standard of care treatment from the Suicide Prevention Team and the Mental Health Service which may include individual therapy, group therapy, and/or medication therapy, all as decided by the individual and his/her doctor. Treatment as usual also includes monitoring by the Suicide Prevention Team.
Experimental: Treatment As Usual with Mind-Body Bridging (TAU + MBB)
Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in four, 90-minute Mind Body Bridging group sessions that will occur for four weeks in a row. Each group will involve up to 15 participants and will be led by a trained MBB facilitator.
Behavioral: Mind Body Bridging Group Session
Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in four, 90-minute Mind Body Bridging group sessions that will occur for four weeks in a row. Each group will involve up to 15 participants and will be led by a trained MBB facilitator. Participants will receive a workbook at the beginning of the training that contains an explanation of all the major concepts involved in Mind Body Bridging. The workbook has homework assignments to be completed daily between group sessions.




Primary Outcome Measures :
  1. Change in frequency and/or intensity of suicidal ideation [ Time Frame: Weekly during the intervention, one-month post-intervention, three months post-intervention, six months post-intervention ]
    Determine if there is a significant difference in the frequency and/or intensity of suicidal ideation, as measured by the Beck Scale for Suicide Ideation (BSS) among the MBB-SI + TAU cohort compared to the TAU. We will use the total BSS score, ranging from 0 to 38. Increased scores reflect greater suicide risk.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects will be Veterans aged 18-70 with psychiatric and/or addictive disorders who are on the High Risk Suicide List because of suicidal ideations and/or behaviors.

Exclusion Criteria:

  • Diagnosis of psychotic spectrum illness and current psychotic symptoms or significant cognitive impairment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03677882


Contacts
Layout table for location contacts
Contact: Don Glover, PhD 8015821565 ext 2325 don.glover@va.gov
Contact: Jessica Vasa, LCSW 8015821565 jessica.vasa@va.gov

Locations
Layout table for location information
United States, Utah
George E. Wahlen Department of Veterans Affairs Medical Center Recruiting
Salt Lake City, Utah, United States, 84148
Contact: Don Glover, PhD    801-558-1565 ext 2325    don.glover@va.gov   
Sponsors and Collaborators
VA Salt Lake City Health Care System
Mind Body Bridging Charity
Investigators
Layout table for investigator information
Principal Investigator: Don Glover, PhD VA Salt Lake City HCS

Layout table for additonal information
Responsible Party: VA Salt Lake City Health Care System
ClinicalTrials.gov Identifier: NCT03677882     History of Changes
Other Study ID Numbers: VASaltLakeCity
First Posted: September 19, 2018    Key Record Dates
Last Update Posted: April 26, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by VA Salt Lake City Health Care System:
mind body bridging
mindfulness
suicidal ideation
suicide related behaviors

Additional relevant MeSH terms:
Layout table for MeSH terms
Suicidal Ideation
Suicide
Self-Injurious Behavior
Behavioral Symptoms